Close Menu

NEW YORK ─ The US Food and Drug Administration has granted Emergency Use Authorization for the Genetrack SARS-CoV-2 Molecular Assay developed by Seattle-based Genetrack Biolabs.

The PCR-based assay is used for the detection of SARS-CoV-2 RNA in anterior nasal swab specimens self-collected at home using the Vo' COVID-19 Test Home Collection Kit. It is designed for people suspected of COVID-19 for whom a healthcare provider has determined that sample self-collection is appropriate.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.